Related Experiment Video
Updated: Jul 28, 2026
06:00
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Histone deacetylase inhibitors: novel anticancer agents
1Epithelial Pathobiology Group, Centre For Immunology & Cancer research, University of Queensland Department of Medicine, Princess Alexandra Hospital, Ipswich Road, Brisbane, Queensland, Australia. NSaunders@medicine.pa.uq.edu.au
Expert Opinion on Investigational Drugs
|January 5, 2001
Summary
Histone deacetylase inhibitors show promise as anticancer agents by restoring gene expression control. These compounds target histone acetylation, crucial for managing cancer development.
Area of Science:
- Molecular Biology
- Cancer Biology
- Pharmacology
Background:
- Gene expression regulation relies on nuclear DNA's nucleosomal integrity.
- Histone acetylation status is a key determinant of nucleosomal integrity.
- Dysregulation of histone acetylases and deacetylases is implicated in human cancers.
Purpose of the Study:
- To explore the rationale for using histone deacetylase inhibitors (HDACis) as anticancer agents.
- To review recent findings on HDACis in cancer therapy.
- To highlight the significance of HDACis in oncology.
Main Methods:
- Review of existing literature on histone deacetylase inhibitors.
- Analysis of studies investigating HDACis in cancer models.
- Synthesis of data on the mechanism of action and efficacy of HDACis.
Main Results:
- Histone deacetylase inhibitors are potent and specific compounds.
- Several novel HDACis have been developed and tested in vivo.
- HDACis demonstrate potential as effective anticancer agents.
Conclusions:
- Histone deacetylase inhibitors represent a promising therapeutic strategy for cancer.
- Further research and clinical trials are warranted to fully establish the role of HDACis in cancer treatment.
- The development of HDACis is a significant advancement in cancer pharmacology.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...